Fulcrum Therapeutics, Inc.
FULC
Revenue
0.00
0.000.00%
-Assets
242.65M
▼-18.07M▼-6.93%
3 Months ChangeLiabilities
14.16M
▼-3.52M▼-19.91%
3 Months ChangeFree Cash Flow
-15.26M
▲10.06M▲39.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-24
Form 8-K
ID: 0000950170-24-109069
2024-09-12
Form 8-K
ID: 0001193125-24-217822
2024-08-22
Form 8-K
ID: 0001193125-24-205347
2024-07-31
Form 10-Q
ID: 0000950170-24-088238
2024-07-31
Form 8-K
ID: 0000950170-24-088236
2024-06-17
Form 8-K
ID: 0001193125-24-162653
2024-05-13
Form 10-Q
ID: 0000950170-24-058193
2024-05-13
Form 8-K
ID: 0000950170-24-058187
2024-02-27
Form 8-K
ID: 0000950170-24-020615
2023-11-07
Form 10-Q
ID: 0000950170-23-059755